Literature DB >> 23238443

Improvement in corneal scarring following bacterial keratitis.

S M McClintic1, M Srinivasan, J Mascarenhas, D A Greninger, N R Acharya, T M Lietman, J D Keenan.   

Abstract

AIM: Bacterial keratitis results in corneal scarring and subsequent visual impairment. The long-term evolution of corneal scars has not been well described. In this case series, we identified patients who had improvement in corneal scarring and visual acuity from a clinical trial for bacterial keratitis.
METHODS: We searched the records of the Steroids for Corneal Ulcers Trial (SCUT) for patients who had improvement in vision between the 3-month and 12-month visits and reviewed their clinical photographs.
RESULTS: Of the 500 patients enrolled in SCUT, five patients with large central corneal scars due to bacterial keratitis are presented. All experienced improvement in rigid contact lens-corrected visual acuity from months 3 to 12. All patients also had marked improvement in corneal opacity during the same time period. None of the patients opted to have penetrating keratoplasty.
CONCLUSIONS: Corneal scars may continue to improve even many months after a bacterial corneal ulcer has healed. The corneal remodeling can be accompanied by considerable improvement in visual acuity, such that corneal transplantation may not be necessary.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23238443      PMCID: PMC3597874          DOI: 10.1038/eye.2012.270

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  5 in total

1.  The steroids for corneal ulcers trial: study design and baseline characteristics.

Authors:  Muthiah Srinivasan; Jeena Mascarenhas; Revathi Rajaraman; Meenakshi Ravindran; Prajna Lalitha; David V Glidden; Kathryn J Ray; Kevin C Hong; Catherine E Oldenburg; Salena M Lee; Michael E Zegans; Stephen D McLeod; Thomas M Lietman; Nisha R Acharya
Journal:  Arch Ophthalmol       Date:  2011-10-10

2.  Corticosteroids for bacterial keratitis: the Steroids for Corneal Ulcers Trial (SCUT).

Authors:  Muthiah Srinivasan; Jeena Mascarenhas; Revathi Rajaraman; Meenakshi Ravindran; Prajna Lalitha; David V Glidden; Kathryn J Ray; Kevin C Hong; Catherine E Oldenburg; Salena M Lee; Michael E Zegans; Stephen D McLeod; Thomas M Lietman; Nisha R Acharya
Journal:  Arch Ophthalmol       Date:  2011-10-10

Review 3.  The molecular basis of corneal transparency.

Authors:  John R Hassell; David E Birk
Journal:  Exp Eye Res       Date:  2010-07-03       Impact factor: 3.467

4.  Global data on visual impairment in the year 2002.

Authors:  Serge Resnikoff; Donatella Pascolini; Daniel Etya'ale; Ivo Kocur; Ramachandra Pararajasegaram; Gopal P Pokharel; Silvio P Mariotti
Journal:  Bull World Health Organ       Date:  2004-12-14       Impact factor: 9.408

5.  Review of epidemiological features, microbiological diagnosis and treatment outcome of microbial keratitis: experience of over a decade.

Authors:  Usha Gopinathan; Savitri Sharma; Prashant Garg; Gullapalli N Rao
Journal:  Indian J Ophthalmol       Date:  2009 Jul-Aug       Impact factor: 1.848

  5 in total
  7 in total

1.  The steroids for corneal ulcers trial (SCUT): secondary 12-month clinical outcomes of a randomized controlled trial.

Authors:  Muthiah Srinivasan; Jeena Mascarenhas; Revathi Rajaraman; Meenakshi Ravindran; Prajna Lalitha; Kieran S O'Brien; David V Glidden; Kathryn J Ray; Catherine E Oldenburg; Michael E Zegans; John P Whitcher; Stephen D McLeod; Travis C Porco; Thomas M Lietman; Nisha R Acharya
Journal:  Am J Ophthalmol       Date:  2013-10-01       Impact factor: 5.258

2.  Smartphone-based Anterior Segment Imaging: A Comparative Diagnostic Accuracy Study of a Potential Tool for Blindness Prevalence Surveys.

Authors:  Ashish Kumar; Ferhina S Ali; Valerie M Stevens; Jason S Melo; N Venkatesh Prajna; Prajna Lalitha; Muthiah Srinivasan; Gopal Bhandari; Sadhan Bhandari; Robi N Maamari; Daniel A Fletcher; Thomas M Lietman; Jeremy D Keenan
Journal:  Ophthalmic Epidemiol       Date:  2021-10-04

3.  Efficacy of systemic vitamin C supplementation in reducing corneal opacity resulting from infectious keratitis.

Authors:  Yong-Wun Cho; Woong-Sun Yoo; Seong-Jae Kim; In-Young Chung; Seong-Wook Seo; Ji-Myong Yoo
Journal:  Medicine (Baltimore)       Date:  2014-11       Impact factor: 1.889

Review 4.  The Corneal Basement Membranes and Stromal Fibrosis.

Authors:  Carla S Medeiros; Gustavo K Marino; Marcony R Santhiago; Steven E Wilson
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-08-01       Impact factor: 4.799

5.  Sustained release of decorin to the surface of the eye enables scarless corneal regeneration.

Authors:  Lisa J Hill; Richard J A Moakes; Chairut Vareechon; Gibran Butt; Aaron Ng; Kristian Brock; Gurpreet Chouhan; Rachel C Vincent; Serena Abbondante; Richard L Williams; Nicholas M Barnes; Eric Pearlman; Graham R Wallace; Saaeha Rauz; Ann Logan; Liam M Grover
Journal:  NPJ Regen Med       Date:  2018-12-21

6.  Characterizing Contact Lens-Related Corneal Infiltrates: A Pilot Study.

Authors:  Meredith E Jansen; Ping Situ; Carolyn G Begley; Danielle Boree; Robin L Chalmers; Kathrine Osborn Lorenz; Tawnya Wilson
Journal:  Cornea       Date:  2016-12       Impact factor: 2.651

7.  Improvement of chronic corneal opacity in ocular surface disease with prosthetic replacement of the ocular surface ecosystem (PROSE) treatment.

Authors:  Anna Cressey; Deborah S Jacobs; Crystal Remington; Karen G Carrasquillo
Journal:  Am J Ophthalmol Case Rep       Date:  2018-02-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.